Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change
17/09/26	€0.6920	0.00%
16/09/26	€0.6920	-2.81%
15/09/26	€0.7120	-2.47%
14/09/26	€0.7300	-6.17%
11/09/26	€0.7780	-4.42%

Real-time Boerse Muenchen

More quotes

Real-time Boerse Muenchen 11:43:13 17/09/2026 BST			5-day change	1st Jan Change
0.6920 ^EUR	0.00%		-17.81%	-19.35%

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Market Cap	2.88M 3.32M 2.72M 2.47M 4.63M 318M 4.65M 32.45M 12.54M 161M 12.47M 12.19M 515M	P/E 2023	3.28x	P/E 2024	-86x
Enterprise Value	3.96M 4.57M 3.74M 3.4M 6.36M 438M 6.4M 44.65M 17.25M 222M 17.15M 16.77M 708M	EV / Sales 2023	1.67x	EV / Sales 2024	0.82x
Free-Float	99.21%	Yield 2023 *	-	Yield 2024	-

Markets		Quality
Euronext Paris	ALKLA	Real-time
Deutsche Boerse AG	4YA	Delayed
Börse Stuttgart	4YA	Delayed
Boerse Muenchen	4YA	Real-time

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
15/10/24	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
29/04/24	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/03/24	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
07/11/23	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
27/10/23	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/04/23	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
09/03/23	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
23/12/22	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
14/12/22	Twitter to shut down newsletter product Revue next year	RE
06/12/22	Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	MT
05/10/22	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	CI

Klarsen Share Price Boerse Muenchen

Stocks

4YA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Chart: Klarsen

Latest news: Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Quotes and Performance

Price Extremes

Managers and Directors: Klarsen

Other IT Services & Consulting

Financials

Company Profile

Quotes

03-03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
02-25	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
12-10	Klarsen : ALKLA-Attribution gratuite de BSA	PU
12-09	Klarsen : ALKLA-ACTIVITE 3T2025	PU
11-27	Klarsen : ALKLA-Résultat augmentation de capital	PU

09-08	Klarsen : calendrier de communication
09-08	Klarsen : ALKLA – Klarsen fait évoluer son calendrier de communication financière et rappelle la tenue de ses Assemblées Générales des 29 septembre et 8 octobre 2026 – 08 Septembre 2026
08-27	Klarsen : ALKLA – Présentation webinaire du 27/08/2026 – Support
08-27	Klarsen : Assemblée générale – 29 Septembre 2026
08-19	Bourse : série de résultats en Europe, flambée d'Unitree et puces Nvidia en Chine

1 week	-17.81%
Current month	-33.78%
1 month	-42.33%
6 months	-26.23%
Current year	-19.35%

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	30/06/2008
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	31/12/2012

Director	Title	Age	Since
Patrice Coffe BRD	Director/Board Member	57	13/06/2010
Gérard Parrou BRD	Director/Board Member	74	26/06/2014
Frédéric Bartoli BRD	Director/Board Member	-	22/03/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	0.00%	-17.81%	-21.00%	-80.45%	2.6M
IBM	-4.38%	-1.02%	-7.78%	+62.68%	224B
ACCENTURE PLC	-1.94%	+7.87%	-19.92%	-39.32%	116B
SNOWFLAKE INC.	+2.49%	-0.14%	+53.29%	+103.82%	117B
TATA CONSULTANCY SERVICES LTD.	+0.05%	-0.64%	-30.98%	-39.27%	82.55B
RELX PLC	+0.49%	+2.53%	-25.88%	-8.29%	59.74B
INFOSYS LIMITED	-0.13%	+2.13%	-30.47%	-29.04%	44.75B
FUJITSU LIMITED	+1.88%	+5.81%	+8.88%	+114.73%	44B
NEC CORPORATION	+1.14%	+6.74%	+8.03%	+191.43%	41.4B
HCL TECHNOLOGIES LIMITED	+0.42%	+4.25%	-15.07%	-3.58%	35.34B
Average	+0.43%	+2.65%	-8.09%	+27.27%	84.92B
Weighted average by Cap.	+0.34%	+1.79%	-4.07%	+38.45%

	2023	2024
Net sales	5.03M 5.8M 4.75M 4.31M 8.08M 556M 8.13M 56.71M 21.91M 282M 21.79M 21.3M 899M	6.31M 7.28M 5.96M 5.42M 10.15M 699M 10.21M 71.21M 27.52M 354M 27.36M 26.75M 1.13B
Net income	2.75M 3.17M 2.6M 2.36M 4.42M 305M 4.45M 31.04M 11.99M 154M 11.92M 11.66M 492M	-47.76K -55.12K -45.15K -40.99K -76.82K -5.29M -77.28K -539K -208K -2.68M -207K -202K -8.55M
Net Debt	-634K -732K -600K -544K -1.02M -70.23M -1.03M -7.16M -2.77M -35.62M -2.75M -2.69M -114M	1.08M 1.25M 1.02M 927K 1.74M 120M 1.75M 12.19M 4.71M 60.68M 4.68M 4.58M 193M

1 week	0.69	0.84
1 month	0.69	1.44
3 years	0	3.69
5 years	0	3.99